ArticleCancer & metabolism2026

BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation of SLC3A2 in pancreatic adenocarcinoma.

Huimin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.